These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Immunization with specific polysaccharide antigen reduces alterations in corneal proteoglycans during experimental slime-producing Staphylococcus epidermidis keratitis. Georgakopoulos CD; Exarchou AM; Gartaganis SP; Kolonitsiou F; Anastassiou ED; Dimitracopoulos G; Hjerpe A; Theocharis AD; Karamanos NK Curr Eye Res; 2006 Feb; 31(2):137-46. PubMed ID: 16500764 [TBL] [Abstract][Full Text] [Related]
23. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model. Romanowski EG; Mah FS; Yates KA; Kowalski RP; Gordon YJ Am J Ophthalmol; 2005 May; 139(5):867-77. PubMed ID: 15860293 [TBL] [Abstract][Full Text] [Related]
24. Comparison of a new enzyme-linked immunosorbent assay method with counterimmunoelectrophoresis for detection of teichoic acid antibodies in sera from patients with Staphylococcus aureus infections. Herzog C; Wood HC; Noel I; Booth JC J Clin Microbiol; 1984 Apr; 19(4):511-5. PubMed ID: 6715518 [TBL] [Abstract][Full Text] [Related]
25. Antibody response to teichoic acid and peptidoglycan in Staphylococcus aureus osteomyelitis. Jacob E; Durham LC; Falk MC; Williams TJ; Wheat LJ J Clin Microbiol; 1987 Jan; 25(1):122-7. PubMed ID: 3098777 [TBL] [Abstract][Full Text] [Related]
26. Role of cell-mediated immunity to staphylococci in blepharitis. Ficker L; Ramakrishnan M; Seal D; Wright P Am J Ophthalmol; 1991 Apr; 111(4):473-9. PubMed ID: 2012150 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of alpha-toxin, capsular polysaccharide (CPS) and recombinant fibronectin-binding protein (r-FnBP) of Staphylococcus aureus in rabbit. Park HM; Yoo HS; Oh TH; Kim D; Han HR J Vet Med Sci; 1999 Sep; 61(9):995-1000. PubMed ID: 10535504 [TBL] [Abstract][Full Text] [Related]
28. Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus. McCormick CC; Caballero AR; Balzli CL; Tang A; O'Callaghan RJ Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2848-54. PubMed ID: 19136695 [TBL] [Abstract][Full Text] [Related]
29. Staphylococcus aureus infection of the rabbit cornea following topical administration. Tang A; Balzli CL; Caballero AR; McCormick CC; Taylor SD; O'Callaghan RJ Curr Eye Res; 2012 Dec; 37(12):1075-83. PubMed ID: 22916736 [TBL] [Abstract][Full Text] [Related]
30. Antibodies to staphylococcal peptidoglycan and its peptide epitopes, teichoic acid, and lipoteichoic acid in sera from blood donors and patients with staphylococcal infections. Wergeland HI; Haaheim LR; Natås OB; Wesenberg F; Oeding P J Clin Microbiol; 1989 Jun; 27(6):1286-91. PubMed ID: 2473994 [TBL] [Abstract][Full Text] [Related]
31. [Induction of delayed hypersensitivity in guinea pigs by staphylococcal cell wall components]. Khorobrykh VV; Pozur VK; Akatov AK Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):90-2. PubMed ID: 3765980 [TBL] [Abstract][Full Text] [Related]
32. Protection against Staphylococcus aureus by antibody to the polyglycerolphosphate backbone of heterologous lipoteichoic acid. Theilacker C; Kropec A; Hammer F; Sava I; Wobser D; Sakinc T; Codée JD; Hogendorf WF; van der Marel GA; Huebner J J Infect Dis; 2012 Apr; 205(7):1076-85. PubMed ID: 22362863 [TBL] [Abstract][Full Text] [Related]
33. Prophylactic gatifloxacin therapy in prevention of bacterial keratitis in a rabbit laser in situ keratomileusis model. Slade DS; Friday JW; Snyder RW; Nix DE; Kleinert LB; Patula VB J Cataract Refract Surg; 2007 May; 33(5):888-92. PubMed ID: 17466866 [TBL] [Abstract][Full Text] [Related]
34. Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit. Dajcs JJ; Thibodeaux BA; Girgis DO; Shaffer MD; Delvisco SM; O'Callaghan RJ Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3712-6. PubMed ID: 12454041 [TBL] [Abstract][Full Text] [Related]
35. Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum. Green SN; Sanders M; Moore QC; Norcross EW; Monds KS; Caballero AR; McDaniel LS; Robinson SA; Onwubiko C; O'Callaghan RJ; Marquart ME Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):290-4. PubMed ID: 18172105 [TBL] [Abstract][Full Text] [Related]
36. [Comparative immunochemical characteristics of extracellular polysaccharide-containing preparations and teichoic acids of Staphylococcus aureus]. Iastrebova NE; Vaneeva NP; Mezhevitinov VB; Stepanova OV Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):14-8. PubMed ID: 3765969 [TBL] [Abstract][Full Text] [Related]